CryoCell Non Recurring from 2010 to 2024

CCEL Stock  USD 8.45  0.33  4.06%   
CryoCell International Non Recurring yearly trend continues to be quite stable with very little volatility. Non Recurring may rise above about 1.2 M this year. From the period between 2010 and 2024, CryoCell International, Non Recurring regression line of its data series had standard deviation of  1,196,686 and standard deviation of  1,196,686. View All Fundamentals
 
Non Recurring  
First Reported
2010-12-31
Previous Quarter
1.2 M
Current Value
1.2 M
Quarterly Volatility
1.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CryoCell International financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CryoCell International's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.1 M, Selling General Administrative of 11.2 M or Total Revenue of 18.4 M, as well as many indicators such as Price To Sales Ratio of 1.56, Dividend Yield of 0.17 or Days Sales Outstanding of 80.52. CryoCell financial statements analysis is a perfect complement when working with CryoCell International Valuation or Volatility modules.
  
Check out the analysis of CryoCell International Correlation against competitors.
For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.

Latest CryoCell International's Non Recurring Growth Pattern

Below is the plot of the Non Recurring of CryoCell International over the last few years. It is CryoCell International's Non Recurring historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CryoCell International's overall financial position and show how it may be relating to other accounts over time.
Non Recurring10 Years Trend
Pretty Stable
   Non Recurring   
       Timeline  

CryoCell Non Recurring Regression Statistics

Arithmetic Mean1,126,966
Geometric Mean0.00
Coefficient Of Variation106.19
Mean Deviation887,893
Median1,212,206
Standard Deviation1,196,686
Sample Variance1.4T
Range3.5M
R-Value0.24
Mean Square Error1.5T
R-Squared0.06
Significance0.39
Slope63,559
Total Sum of Squares20T

CryoCell Non Recurring History

20241.2 M
20231.2 M
20191.3 M
20182.3 M
2016null
20153.5 M
20143.4 M

About CryoCell International Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include CryoCell International income statement, its balance sheet, and the statement of cash flows. CryoCell International investors use historical funamental indicators, such as CryoCell International's Non Recurring, to determine how well the company is positioned to perform in the future. Although CryoCell International investors may use each financial statement separately, they are all related. The changes in CryoCell International's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on CryoCell International's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on CryoCell International Financial Statements. Understanding these patterns can help to make the right decision on long term investment in CryoCell International. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Recurring1.2 M1.2 M

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as CryoCell International using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Information and Resources on Investing in CryoCell Stock

When determining whether CryoCell International is a strong investment it is important to analyze CryoCell International's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CryoCell International's future performance. For an informed investment choice regarding CryoCell Stock, refer to the following important reports:
Check out the analysis of CryoCell International Correlation against competitors.
For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.25)
Earnings Share
(1.16)
Revenue Per Share
3.783
Quarterly Revenue Growth
0.004
Return On Assets
(0.01)
The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.